December 6, 2015

Clyde & Co advises NMC Health on acquisition of an interest in Fakih IVF Group

Clyde & Co has advised NMC Health, the UAE's largest healthcare provider, on a US$189 million acquisition of a 51% shareholding in Fakih IVF Group.

We were delighted to work with and assume the responsibility of lead transaction counsel for NMC again on this significant transaction requiring comprehensive sectoral and legal knowledge of various areas of law, multiple jurisdictions and relevant applicable laws

This is the second major acquisition in the health care sector this year that Clyde & Co has advised NMC Health on, following the US$160.6 million acquisition of ProVita announced in June this year.

Relationship partner Abhi Jalan said: "We were delighted to work with and assume the responsibility of lead transaction counsel for NMC again on this significant transaction requiring comprehensive sectoral and legal knowledge of various areas of law, multiple jurisdictions and relevant applicable laws."

Clyde & Co's team was led by Partner Abhi Jalan and Legal Director, Naji Hawayek with assistance from Munisha Khatwani, Raeesa Chowdhury, James Marriner, Neil Williams and Ghalya Rashid Ali (Corporate Group), Carl Fennessy (Intellectual Property Group) and Sara Khoja (Employment Group).

Clyde & Co has a well-established healthcare practice with significant capabilities covering a wide range of legal services within the sector. With a proven track record of providing advice and support in relation to mergers and acquisitions, the Clyde & Co healthcare team understand the key issues facing clients within the sector. Our healthcare clients include private equity firms specialising in healthcare investments, health ministries and authorities, public and private hospitals, pharmaceutical companies, insurance companies, healthcare suppliers and distributors as well as healthcare companies emerging or restructuring in GCC markets.